Literature DB >> 25444889

Use of meconium in perinatal epidemiology: potential benefits and pitfalls.

Bo Y Park1, Brian K Lee2.   

Abstract

PURPOSE: Meconium is a biomarker matrix that can be used to assess cumulative exposures in epidemiologic studies of prenatal risk factors. Depending on when meconium is collected, different exposure windows during pregnancy can be measured. However, little guidance exists regarding the extent to which timing of meconium collection will influence resulting effect estimates.
METHODS: We performed a simulation study of prenatal tobacco smoke exposure (assessed from meconium nicotine) and birth weight. We discuss four typical meconium collection methods capturing different exposure windows and assess the biases induced by these methods.
RESULTS: In simulations assuming that exposure to tobacco smoke only during late gestation was of etiologic relevance to birth weight, use of a meconium collection method that captured exposure windows other than late gestation resulted in biased estimates of the true nicotine-birth weight association.
CONCLUSIONS: Using meconium collection methods that do not reflect an exposure window of etiologic relevance can lead to biased results and erroneous conclusions regarding the nature of prenatal exposure-outcome associations. Understanding how prenatal exposure patterns vary across the pregnancy and exposure windows of etiologic relevance is essential in determining when and how to collect meconium for use in biomarker studies of prenatal exposure.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Epidemiology; Exposure assessment; Low birth weight; Meconium; Nicotine; Smoking

Mesh:

Substances:

Year:  2014        PMID: 25444889     DOI: 10.1016/j.annepidem.2014.09.009

Source DB:  PubMed          Journal:  Ann Epidemiol        ISSN: 1047-2797            Impact factor:   3.797


  6 in total

1.  Comparison of protease and aminopeptidase activities in meconium: A pilot study.

Authors:  Ewa Skarżyńska; Paulina Wilczyńska; Bartosz Kiersztyn; Joanna Żytyńska-Daniluk; Artur Jakimiuk; Barbara Lisowska-Myjak
Journal:  Biomed Rep       Date:  2020-06-09

2.  Second trimester amniotic fluid bisphenol A concentration is associated with decreased birth weight in term infants.

Authors:  Sara E Pinney; Clementina A Mesaros; Nathaniel W Snyder; Christine M Busch; Rui Xiao; Sara Aijaz; Naila Ijaz; Ian A Blair; Jeanne M Manson
Journal:  Reprod Toxicol       Date:  2016-11-06       Impact factor: 3.143

3.  Differences in testosterone and its precursors by sex of the offspring in meconium.

Authors:  Alexander J Frey; Bo Y Park; Emily R Schriver; Daniel R Feldman; Samuel Parry; Lisa A Croen; Daniele M Fallin; Irva Hertz-Picciotto; Craig J Newschaffer; Nathaniel W Snyder
Journal:  J Steroid Biochem Mol Biol       Date:  2016-11-18       Impact factor: 4.292

4.  Preliminary results of identification and quantification of paclitaxel and its metabolites in human meconium from newborns with gestational chemotherapeutic exposure.

Authors:  Elyce Cardonick; Robert Broadrup; Peining Xu; Mary T Doan; Helen Jiang; Nathaniel W Snyder
Journal:  PLoS One       Date:  2019-02-20       Impact factor: 3.240

5.  In Utero Exposure to Caffeine and Acetaminophen, the Gut Microbiome, and Neurodevelopmental Outcomes: A Prospective Birth Cohort Study.

Authors:  Hannah E Laue; Yike Shen; Tessa R Bloomquist; Haotian Wu; Kasey J M Brennan; Raphael Cassoulet; Erin Wilkie; Virginie Gillet; Anne-Sandrine Desautels; Nadia Abdelouahab; Jean Philippe Bellenger; Heather H Burris; Brent A Coull; Marc G Weisskopf; Wei Zhang; Larissa Takser; Andrea A Baccarelli
Journal:  Int J Environ Res Public Health       Date:  2022-07-30       Impact factor: 4.614

6.  Meconium androgens are correlated with ASD-related phenotypic traits in early childhood in a familial enriched risk cohort.

Authors:  Dina Terloyeva; Alexander J Frey; Bo Y Park; Elizabeth M Kauffman; Leny Mathew; Anna Bostwick; Erika L Varner; Brian K Lee; Lisa A Croen; Margaret D Fallin; Irva Hertz-Picciotto; Craig J Newschaffer; Kristen Lyall; Nathaniel W Snyder
Journal:  Mol Autism       Date:  2020-11-23       Impact factor: 6.476

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.